Skip to main content Back to Top
Advertisement

ASHP Launches New COVID-19 Microsite

Broadcast Date: April 21, 2020

 

Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

Today on ASHPOfficial, we chat with Eric Maroyka about the transformation of our frequently accessed COVID-19 Resource Center into a new microsite that intuitively organizes the resources needed to effectively plan and respond to the pandemic. The microsite includes resources available to pharmacists related to treatment and supportive care, drug information, surveillance and tracking, knowledge and skill development, planning and readiness, advocacy efforts, and infection prevention. ASHP will continue to enhance the site with new and updated content, which remains open to all healthcare professionals engaged in the COVID-19 response.

SPEAKERS

Eric MaroykaEric Maroyka, Pharm.D., BCPS, joined ASHP in May 2016 as the Director, Center on Pharmacy Practice Advancement. He is responsible for the Practice Advancement Initiative focused on transforming the practice of pharmacy to enhance the role of the pharmacist in providing direct patient care services.

Prior to his current position, he served as the Director of Pharmacy at Fauquier Health in Warrenton, Virginia. Dr. Maroyka also served over 22 years as a commissioned pharmacy officer in the United States Army working in a variety of clinical, pharmacy management/director, and senior leadership roles within the Military Health System.

He earned a Bachelors Degree in Pharmacy and Pharm.D. from Rutgers University and completed a PGY1 Pharmacy Practice Residency at Walter Reed Army Medical Center.  Dr. Maroyka is a Board Certified Pharmacotherapy Specialist and is a graduate of the Pharmacy Leadership Institute.

Dr. Maroyka was a past appointed member of the ASHP Section of Pharmacy Practice Managers Section Advisory Group on Pharmacy Business Management and the Council on Pharmacy Management.  He served as a delegate to the ASHP House of Delegates representing the Commonwealth of Virginia and as a Federal Delegate with the American Pharmacists Association.  He currently serves as ASHP Secretary for the Council on Pharmacy Management and secretary for the Federal Pharmacy Consultants’ Advisory Group.  Dr. Maroyka readily accepts and enjoys serving as a preceptor for student pharmacists and pharmacy residents. 

Vicki BasalygaVicki Basalyga, Pharm.D., BCPS, BCPPS, is the Director for the Section of Clinical Specialists and Scientists. In this role Vicki serves as an information resource and provides guidance to ASHP members regarding science and scientific developments affecting pharmacy practice in health systems. She serves as secretary to the Section executive committee and coordinates activities to accomplish the objectives established by the Section. Additionally, Vicki has assumed the position of Council Secretary for the ASHP's Council on Therapeutics.

Vicki received her Doctor of Pharmacy from Duquesne University and completed an ASHP accredited PGY1 at Children’s National Medical Center in Washington, DC. Vicki is also a Board Certified Pharmacotherapy Specialist and a Board Certified Pediatric Pharmacotherapy Specialist.

Prior to her current position at ASHP, Vicki practiced as critical care pharmacist in both the Cardiac Intensive Care Unit and the Pediatric Intensive Care Unit at Children’s National Medical Center in Washington, DC. Other activities Vicki performed included drafting policies and procedures, co-chairing the Antimicrobial Stewardship Program, creating and drafting order sets for CPOE conversion and precepting residents and students.



The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.